Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210034896 210010995 1.75 84.8 null 2015-06-14 2015-06-14 IDELALISIB + RITUXIMAB null null 210028034 IDELALISIB + RITUXIMAB
210034897 210011010 0 76.6 Disease modification (D) null 2016-12-18 METHOTREXATE 2 N 210028083 METHOTREXATE
210034898 210011023 1.7 74.5 Curative (C) 2018-09-11 2018-09-11 Imatinib 400mg N N 210028127 IMATINIB
210034899 210021151 null null Curative (C) 2018-01-28 2019-01-19 R Chlorambucil 02 N 210028183 CHLORAMBUCIL + RITUXIMAB
210034900 210011093 null null null 2015-12-29 2015-12-29 IMATINIB 99 null 210028382 IMATINIB
210034901 210011105 1.8 87.3 Curative (C) 2018-01-26 2018-01-26 ALL UKALL60+ TRIAL N N 210028430 UKALL60+
210034902 210011107 null 84 Curative (C) 2018-05-12 2018-10-21 METHOTREXATE 2 N 210028437 METHOTREXATE
210034903 210021190 1.65 null Curative (C) 2016-01-11 2016-03-05 ALL UKALL2003 TRIAL Y N 210028497 UKALL 2003
210034904 210011171 1.59 67 Disease modification (D) 2016-08-03 2016-11-20 Triple / Double Intrathecal Therapy 2 N 210028647 TRIPLE INTRATHECAL
210034905 210011225 1.65 0 Adjuvant (A) 2013-06-05 2013-08-05 Imatinib 400mg N N 210028830 IMATINIB
210034906 210011248 1.71 69.4 Curative (C) 2018-01-17 2018-01-23 METHOTREXATE N N 210028900 METHOTREXATE
210034907 210021255 1.66 69.3 Curative (C) 2017-12-23 2018-03-24 ALL UKALL2003 TRIAL N N 210028901 UKALL 2003
210034908 210011261 1.52 77.7 Disease modification (D) 2015-02-02 2015-07-08 METHOTREXATE 02 N 210028914 METHOTREXATE
210034909 210011296 null 93.25 Palliative (P) 2015-06-12 2015-09-04 ALL UKALL60+ TRIAL N N 210029077 UKALL60+
210034910 210011301 0 89 null 2016-07-16 2016-07-23 IMATINIB 2 N 210029102 IMATINIB
210034911 210011315 1.63 84 Curative (C) 2015-06-25 2016-01-03 Imatinib 400mg 02 N 210029159 IMATINIB
210034912 210011320 null 88.4 Disease modification (D) 2014-06-21 2015-11-19 R Chlorambucil 02 null 210029163 CHLORAMBUCIL + RITUXIMAB
210034913 210011326 null null Curative (C) 2016-11-19 2016-11-19 ALL UKALL2003 TRIAL null null 210029191 UKALL 2003
210034914 210011332 1.59 80 Disease modification (D) 2019-04-01 2019-04-01 IMATINIB N N 210029196 IMATINIB
210034915 210011360 1.87 null Adjuvant (A) 2018-06-01 2018-08-31 ALL UKALL2003 TRIAL N N 210029276 UKALL 2003
210034916 210011364 1.8 100.9 Curative (C) 2016-08-06 2016-08-11 Triple / Double Intrathecal Therapy 02 N 210029291 TRIPLE INTRATHECAL
210034917 210011411 1.79 88.2 Palliative (P) 2013-10-28 2014-04-20 CHLORAMBUCIL + OBINUTUZUMAB N N 210029448 CHLORAMBUCIL + OBINUTUZUMAB
210034918 210011424 0 94.5 Disease modification (D) 2019-05-10 2019-08-09 IDELALISIB + RITUXIMAB N N 210029502 IDELALISIB + RITUXIMAB
210034919 210011488 1.6 72.5 Disease modification (D) 2018-07-25 2018-07-25 Imatinib 600mg N N 210029804 IMATINIB
210034920 210011496 0 98.4 Adjuvant (A) 2018-08-10 2018-09-22 ALL UKALL60+ TRIAL 1 N 210029832 UKALL60+
210034921 210011508 1.86 66 Curative (C) 2017-03-27 2017-04-10 Triple / Double Intrathecal Therapy 2 N 210029884 TRIPLE INTRATHECAL
210034922 210011538 1.6 67.8 Curative (C) 2018-10-11 2018-11-09 CHLORAMBUCIL + RITUXIMAB Y N 210030000 CHLORAMBUCIL + RITUXIMAB
210034923 210011546 1.85 95.8 Curative (C) 2018-06-24 2018-09-16 IMATINIB N N 210030013 IMATINIB
210034924 210021396 null 73.9 Curative (C) 2014-09-17 2016-04-20 ALL UKALL60+ TRIAL null Y 210030014 UKALL60+
210034925 210011569 null 73.9 Curative (C) 2016-08-13 2016-12-27 Triple Intrathecal Y null 210030141 TRIPLE INTRATHECAL
210034926 210011579 null null Curative (C) null 2017-10-31 IMATINIB N N 210030161 IMATINIB
210034927 210011581 1.58 90.15 Palliative (P) 2018-12-25 2019-04-30 Imatinib 400mg N N 210030163 IMATINIB
210034929 210011638 1.76 82 Adjuvant (A) 2016-11-05 2017-04-06 ALL UKALL2003 B: Ph VII Maintenance Y N 210030435 UKALL 2003
210034930 210011674 1.62 64.3 Palliative (P) 2016-01-05 2016-01-20 Triple Intrathecal 2 N 210030624 TRIPLE INTRATHECAL
210034931 210011725 1.86 94.5 Curative (C) 2017-01-07 2017-05-11 METHOTREXATE 02 N 210031008 METHOTREXATE
210034932 210011732 1.86 13.8 Curative (C) 2015-09-14 2016-05-20 ALL Int Gde A/B DInt PhIV pt1 PAsp N N 210031025 ALL INTENSIFICATION
210034933 210021507 null 67.3 Curative (C) 2016-02-23 2016-04-04 Mercaptopurine N N 210031164 MERCAPTOPURINE
210034934 210027514 1.75 null Curative (C) 2017-06-04 2017-12-08 ALL Int Gde A/B DInt PhIV pt1 PAsp Y N 210031465 ALL INTENSIFICATION
210034935 210011825 null 105.9 Curative (C) 2017-09-14 2018-01-05 ALL ALLR3 FLAD Phase IV Y N 210031507 UKALLR3
210034936 210011833 null 41.1 Curative (C) 2017-07-22 2018-04-06 ALL Int GdeC D Int PhIV recon Pasp Y N 210031516 ALL INTENSIFICATION
210034937 210027525 1.57 69.3 Curative (C) 2014-01-05 2014-06-05 Blinatumomab Y N 210031542 BLINATUMOMAB
210034938 210011845 1.82 108.5 Curative (C) 2016-11-06 2016-11-07 ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) 01 N 210031570 UKALLR3
210034940 210011874 null 19.2 Curative (C) 2016-09-08 2018-12-13 MERCAPTOPURINE + METHOTREXATE N N 210031749 MERCAPTOPURINE + METHOTREXATE
210034941 210011887 1.68 null Disease modification (D) 2013-05-20 2014-07-28 CHOP R - 21 days Y null 210031805 CHOP R
210034942 210011889 1.64 52 Palliative (P) 2016-01-08 2016-02-19 Mercaptopurine N N 210031811 MERCAPTOPURINE
210034943 210031198 null 97.2 Palliative (P) 2016-03-23 2016-09-07 CHOP R - 21 days N N 210031879 CHOP R
210034944 210011921 null 74 null 2016-05-08 2016-11-09 ALL Int GdeC D Int PhIV recon Pasp N N 210032019 ALL INTENSIFICATION
210034945 210011926 null 78 Curative (C) 2014-02-07 2014-02-07 Alemtuz+Fludara+Melphalan RIC MUD N null 210032021 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
210034946 210027556 1.82 85.1 Curative (C) 2013-03-26 2014-08-21 ALL Int Guide A/B/C Maint Ph V Y N 210032022 ALL INTERIM GUIDELINES
210034948 210012006 1.73 51.2 Curative (C) 2018-02-16 2018-02-16 Venetoclax N N 210032587 VENETOCLAX